These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 36454465)

  • 1. Genome Editing in Dyslipidemia and Atherosclerosis.
    Chen Z; Lehertshuber C; Schunkert H
    Adv Exp Med Biol; 2023; 1396():139-156. PubMed ID: 36454465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome editing in cardiovascular diseases.
    Mani I
    Prog Mol Biol Transl Sci; 2021; 181():289-308. PubMed ID: 34127197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia.
    Chadwick AC; Musunuru K
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):12-18. PubMed ID: 28838920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Editing in Translational Medicine: An Inventory.
    Dobner J; Ramachandran H; Rossi A
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):241. PubMed ID: 36042173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome Editing and Pathological Cardiac Hypertrophy.
    Kato T
    Adv Exp Med Biol; 2023; 1396():87-101. PubMed ID: 36454461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
    Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
    J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genome-editing: focus on the off-target effects].
    He X; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas systems: Challenges and future prospects.
    Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
    Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications.
    Phan HTL; Kim K; Lee H; Seong JK
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Application of Genome Editing Technologies in Viral Diseases.
    Kim TH; Lee SW
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing and Its Applications in Model Organisms.
    Ma D; Liu F
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery Approaches for Therapeutic Genome Editing and Challenges.
    Ates I; Rathbone T; Stuart C; Bridges PH; Cottle RN
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32977396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
    Bayarsaikhan D; Bayarsaikhan G; Lee B
    Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
    Li H; Yang Y; Hong W; Huang M; Wu M; Zhao X
    Signal Transduct Target Ther; 2020 Jan; 5(1):1. PubMed ID: 32296011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.